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Abstract
Background: Biomarkers of iron status are affected by inflammation. In order to interpret them in individuals with
inflammation, the use of correction factors (CFs) has been proposed.
Objective: The objective of this study was to investigate the use of regression models as an alternative to the CF
approach.
Methods: Morbidity data were collected during clinical examinations with morbidity recalls in a cross-sectional study in
children aged 6–23 mo with moderate acute malnutrition. C-reactive protein (CRP), a1-acid glycoprotein (AGP), serum
ferritin (SF), and soluble transferrin receptor (sTfR) were measured in serum. Generalized additive, quadratic, and linear
models were used to model the relation between SF and sTfR as outcomes and CRP and AGP as categorical variables
(model 1; equivalent to the CF approach), CRP and AGP as continuous variables (model 2), or CRP and AGP as continuous
variables and morbidity covariates (model 3) as predictors. The predictive performance of the models was compared with
the use of 10-fold crossvalidation and quantified with the use of root mean square errors (RMSEs). SF and sTfR were
adjusted with the use of regression coefficients from linear models.
Results: Crossvalidation revealed no advantage to using generalized additive or quadratic models over linear models in
terms of the RMSE. Linear model 3 performed better thanmodels 2 and 1. Furthermore, we found no difference in CFs for
adjusting SF and those from a previous meta-analysis. Adjustment of SF and sTfR with the use of the best-performing
model led to a 17% point increase and <1% point decrease, respectively, in estimated prevalence of iron deficiency.
Conclusion: Regression analysis is an alternative to adjust SF and may be preferable in research settings, because it can
takemorbidity and severity of inflammation into account. In clinical settings, the CF approachmay bemore practical. There
is no benefit from adjusting sTfR. This trial was registered at www.controlled-trials.com as ISRCTN42569496. J Nutr
2017;147:125–32.
Keywords: inflammation, a1-acid glycoprotein, correction factors, C-reactive protein, iron deficiency,
regression analysis, serum ferritin, soluble transferrin receptor, young children
Introduction
Anemia is a major public health issue and affects an estimated
71% of young children <5 y of age in western and central Africa
(1). It can cause fatigue and has been associated with poor
cognitive and motor development (2). Iron deficiency (ID)8 is
believed to be responsible for 50% of anemia cases (3). Other
3 Supplemental Table 1 is available from the ‘‘Online Supporting Material’’ link in
the online posting of the article and from the same link in the online table of
contents at http://jn.nutrition.org.
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error; SF, serum ferritin; sTfR, soluble transferrin receptor.
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causes of anemia include infectious diseases, hemoglobinopathies,
and deficiencies of folate, vitamin B-12, or vitamin A (2, 4).
Diagnosis of ID is necessary for a better understanding of the
causes of anemia, identifying individuals who are most likely to
benefit from iron supplements, and evaluating the effectiveness
of interventions to combat anemia. It is, however, a challenge
because biomarkers of iron status, namely serum ferritin (SF)
and serum soluble transferrin receptor (sTfR), are affected by
inflammation (4, 5). More specifically, SF acts as a positive
acute-phase reactant (6). sTfR is believed to be less affected
by inflammation (4), although there are discrepancies in the
literature regarding the relation between inflammation, infec-
tion, and sTfR. Some studies have shown that sTfR decreases in
the presence of inflammation (6, 7) and malaria (8), whereas
others found higher concentrations of sTfR in individuals with
malaria (9, 10) or observed positive relations between inflam-
mation markers and sTfR (10–14). It is unclear what causes
these discrepancies, but they may be due in part to different
levels of immunity, time course and severity of infection, and the
infection causing the inflammation and anemia.
In order to interpret biomarkers of iron status in the presence of
inflammation, Thurnham et al. (15, 16) have suggested applying
correction factors (CFs) to measured concentrations of SF in
individuals with inflammation, defined as elevated serum con-
centrations of the acute-phase proteins (APPs) serum C-reactive
protein (CRP) and/or seruma1-acid glycoprotein (AGP). Although
it is widely accepted that SF needs to be adjusted for inflammation
(10, 14, 15, 17–21), it is still debated whether it is necessary to
adjust sTFR (10, 21–23).
The CF approach is easy to apply and has been used in a number
of studies (10, 14, 17–20). However, it relies on single cutoffs, and
therefore ignores the fact that the impact of inflammation on
biomarkers of iron status depends on the severity of the inflam-
mation (11, 23) andmay also depend on the cause of inflammation.
In contrast, regression modeling, which has been proposed as an
alternative to the CF approach (24), is not dependent on cutoffs,
and has the advantage that it can take morbidity covariates into
account. It therefore may be a better option in populations with a
high prevalence of infections. One concern about the use of linear
regression models is that relations between APPs, namely CRP and
AGP, and biomarkers of iron status are not linear (24); thus, it may
be necessary to use more flexible regression models. Regression
models previously have been used to adjust for inflammation
(22, 23), but more studies are needed, in particular in contexts in
which infections as well as malnutrition are common.
The objective of this study (ISRCTN42569496) was to inves-
tigate the use of regression models in adjusting biomarkers of iron
status for the effect of inflammation in young children with
moderate acute malnutrition in Burkina Faso, where, as previously
shown, inflammation and morbidity are common (25).
Methods
Study area and population. The data for this paper were baseline data
collected as part of the Treatfood trial, a randomized trial with the
objective of assessing the effectiveness of 12 supplementary foods for
treatment of moderate acute malnutrition, defined as a weight-for-height
z score between –3 and –2 and/or a midupper arm circumference
(MUAC) between 115 and 125 mm. As previously described (26), the
trial was carried out in 5 health centers in the Province du Passore´,
Burkina Faso. The study catchment area covered a total of 143 villages
and a total population of ;258,000.
Children aged 6–23 mo with moderate acute malnutrition who were
residents in the catchment area and whose parents or guardians provided
consent for their children to participate were included. Children who
were hospitalized or treated for severe acute malnutrition in the previous
2 mo, children with hemoglobin <5 g/dL, children who were already
enrolled in a nutritional program, and those who had medical compli-
cations requiring hospitalization were not included. Screening for partici-
pants was carried out by community health workers with the use of MUAC
tapes and designated screening teams that used bothMUAC andweight-for-
height z score. In addition, children could be referred from a health center or
could present on site at the initiative of the caregiver. Recruitment took place
from September 2013 until August 2014.
Data collection. Sociodemographic data were collected by trained
interviewers. Body weight was measured to the nearest 0.1 kg with the
use of an electronic scale with double weighing function (Seca model 881
1021659). Length was measured to the nearest 0.1 cm with the use of a
standard UNICEFwoodenmeasuring board. All children were measured
while lying down. MUAC was measured on the left arm to the nearest
1 mm. During clinical examinations and 14-d retrospective morbidity
interviews, research nurses collected the following morbidity data:
rash, skin infection, runny nose, cough, ear discharge, upper respiratory
infection, lower respiratory infection, diarrhea, fever, and malaria, as
well as history of fever, cough, diarrhea, vomiting, rash and swelling.
Venous blood (2.5 mL) was collected from the arm. One drop was used
for diagnosis of malaria with the use of a rapid diagnostic test that
detects histidine-rich protein 2 synthesized by the Plasmodium
falciparum malaria parasite (Bioline, Malaria Ag P.f; Standard Diagnos-
tics), and 1 drop of blood was used to estimate hemoglobin concentra-
tion with the use of a HemoCue device (HB 301). The HemoCue was
calibrated at the end of every month with a control solution. The
remaining blood was added to a sample tube with clot activator (BD
reference no. 368492) and transported to the trial lab in a cold box at
2–8C. Serum was isolated after centrifugation at 700 3 g for 5 min
(EBA 20 S; Hettich) at room temperature and stored at 220C until
shipment to the VitMin Lab in Willstaedt, Germany, for analysis of CRP,
AGP, SF, and sTfR with the use of a combined sandwich ELISA (27). All
samples were measured in duplicate, and both intra- and interassay CVs
were <10%. Samples were frozen and thawed only once before analysis.
The thresholds used for defining abnormal values were as follows:
hemoglobin <11 g/L (28); SF <12 mg/L (28); sTfR >8.3 mg/L (27); CRP
>5 mg/L (24); AGP >1 g/L (24). Fever was defined as an axillary
temperature$37.5C. Upper and lower respiratory tract infections were
diagnosed by experienced pediatric nurses on the basis of an adapted
version of the Integrated Management of Childhood Illnesses guidelines
(29, 30). Diarrhea was defined as $3 loose watery stools/d.
Data handling and statistical analysis. Data were double entered into
Epidata 3.1 software, and double-entry checks were carried out on a daily
basis. All statistical analyses were carried out with the use of the statistical
software R (31). P values < 0.05 were considered to be significant.
Characteristics of the study populationwere summarized as percentages,
means 6 SDs, or, if not normally distributed, as medians (IQRs). Scatter
plots with a best-fitting local regression curve were used to display any
possible nonlinear relations between biomarkers of iron status and APPs.
Three types of models were used to predict logarithm-transformed
SF and sTfR, namely, generalized additive models (GAMs), which
flexibly allow modeling of nonlinear relations, quadratic models, and
linear models. For each of these 3 model types, 5 models for each iron
status biomarker as outcome were built with 1) CRP as a continuous
variable, 2) AGP as a continuous variable, 3) CRP and AGP as continuous
variables, 4) both APPs and morbidity covariates, or 5) inflammation
groups as independent variables. The inflammation groups used were
no inflammation, incubation (CRP >5 mg/L only), early convalescence
(CRP >5 mg/L and AGP >1 g/L), and late convalescence (AGP >1 g/L
only), as previously described by Thurnham et al. (15). Stepwise
backward elimination was used for variable selection. The first 4
models were fitted to the subset of the data that consisted of individuals
who had a CRP >5 mg/L and/or AGP >1 g/L, and the last model was
built in the full dataset, because the base category was children without
inflammation. Model checking was based on residual and normal
probability plots.
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The predictive performance of the models was compared with the use
of 10-fold crossvalidation. More specifically, the data set was randomly
split into 10 subsets of equal size. In turn, each of these subsets of the
data set (test set) was left out, and models were fitted to the remainder
part of the data (training set). For both SF and sTfR, predictive
performance was evaluated with the use of root mean squared errors
(RMSEs) between observed and predicted values, where a lower RMSE
indicated better performance.
After the crossvalidation, adjusted SF and sTfR concentrations were
calculated with the use of regression coefficients from the models. As an
example, the formula for calculation of adjusted SF concentrations with
the use of the model with both CRP and AGP as independent variables
would be as follows: Adjusted SF = exp(log SF2 bCRP3 CRP2 bAGP3
AGP), where bCRP is the regression coefficient from the model and logSF
is logarithm transformed SF.
Only concentrations in individuals with CRP >5 mg/L and/or AGP
>1 g/L were adjusted. Because back-transformed regression coefficients
from logarithm-transformed models are equal to the ratio of geometric
means, the model with inflammation groups as an independent variable
corresponds to the CF approach previously described by Thurnham
et al. (15, 16), where ratios of geometric means are converted to
correction multipliers by dividing 1 by the ratio. We compared our
results with the ratios calculated in a meta-analysis (15) for both
infants (<12 mo of age) and children (<18 y of age) with the use of
approximate t tests. Prevalence of ID was calculated for unadjusted
and adjusted values, as well as separately for individuals with and
without inflammation based on the cutoffs for SF and sTfR mentioned
above.
TABLE 1 Characteristics of 1564 children aged 6–23 mo with
moderate acute malnutrition in Burkina Faso1
Characteristic Value
Sex, M 45.1 (706)
Age, mo 11.4 [8.2–16.2]
Anthropometric measurements
Inclusion category
Low MUAC2 only 29.0 (454)
Low WHZ3 and low MUAC2 50.1 (784)
Low WHZ3 only 20.8 (326)
HAZ ,22 37.7 (590)
Morbidity
Illness according to maternal recall4 37.5 (587)
Illness according to physical examination 71.6 (1121)
Malaria4 40.2 (626)
Laboratory tests
Serum CRP, mg/L 2.3 [0.8–9.4]
0–5 64.1 (1002)
.5–10 11.7 (183)
.10–20 9.2 (144)
.20–40 7.0 (110)
.40 8.0 (125)
Serum AGP, g/L 1.2 [1.19–1.24]
0–1 33.0 (517)
.1–2 52.4 (819)
.2–3 10.8 (169)
.3 3.8 (59)
Hemoglobin, g/L 10.0 6 1.6
,11 70 (1095)
1 Values are % (n) for categorical variables, means6 SDs for continuous variables with
a normal distribution, or medians [IQRs] for continuous variables with a skewed
distribution. AGP, a1-acid glycoprotein; CRP, C-reactive protein; HAZ, height-for-age z
score; MUAC, midupper arm circumference; WHZ, weight-for-height z score.
2 MUAC $115 mm and ,125 mm.
3 WHZ $23 and ,22.
4 Data missing: Ill according to maternal recall, n = 9; malaria, n =6.
FIGURE 1 Relation between acute-phase proteins and biomarkers of
iron status in 1564 children aged 6–23 mo. Relation between CRP and
SF (A); relation between CRP and sTfR (B); relation between AGP and
SF (C); and relation between AGP and sTfR (D). The gray dots represent
serum concentrations of iron status biomarkers (SF or sTfR). The solid
black line is the best-fitting local regression curve with 95% CI. The
dotted line indicates the cutoff used to define inflammation, i.e., 5 mg/L
for CRP and 1 g/L for AGP. AGP, a1-acid glycoprotein; CRP, C-reactive
protein; SF, serum ferritin; sTfR, soluble transferrin receptor.
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Ethical considerations. The study was approved by the Ethics Commit-
tee for Health Research of the government of Burkina Faso (2012–8-059),
and consultative approval was obtained from the Danish National
Committee on Biomedical Research Ethics (1208204). The study was
carried out in accordance with the Declaration of Helsinki. All children
recruited in need of medical treatment received treatment free of charge
according to an adapted version of the Integrated Management of
Childhood Illnesses guidelines (29, 30) and national protocol. Consent
was obtained from caregivers before inclusion, verbally and in writing
(signature or fingerprints). Data were kept confidential and in a locked
facility.
Results
Sample population characteristics. As previously reported,
1609 children were enrolled in the Treatfood study (25). Among
these, 1564 children (82.1%) had baseline SF and sTfR data and
were included in the analysis presented here. Background charac-
teristics are presented in Table 1 and have been described in
more detail elsewhere (25). As previously reported, infections
and inflammation were common (25). More than two-thirds of
children had a symptom or infection diagnosed during the physical
examination, 35.8% (n = 561) had elevated CRP concentra-
tions, and 66.4% (n = 1039) had elevated AGP concentrations
(Table 1). Only 11.1% (n = 174) of children did not have any
inflammation, history of illness, or infections. Anemia was also
common (Table 1).
Model selection: SF. Although the relation between SF and
APPs was not completely linear, as shown in Figure 1 A and B
and also confirmed by the GAM (P value of smooth terms < 0.05),
SF appeared to steadily increase for APP values above the cutoff
indicating inflammation, and leveled off at high concentra-
tions of the APPs (Figure 1 A and B). In line with the latter
observation, crossvalidation revealed no advantage of using
more complex GAMs and quadratic models over linear models
in terms of the RMSEs, which were 0.953, 0.952, and 0.957 for
the GAMs and quadratic and linear models, respectively, with
APPs in continuous form as predictors. Because there appears to
be no gain from using more complex models, the remainder of the
analysis was based on linear models. Althoughmodel type did not
greatly affect the predictive performance of the models, the choice
of covariates had more of an impact. The RMSEs were reduced if
both APPs were included as continuous rather than categorical
variables, and they were further reduced if morbidity data were
included in addition to APPs (Table 2). APPs, malaria, and lower
respiratory tract infection, as well as history of fever, were
significantly associated with increased log SF concentrations
(Table 2). RMSEs for models not presented in Table 2 can be
found in Supplemental Table 1.
Model selection: serum sTfR. Similarly to SF, the relation
between sTfR and APPs was not completely linear, as demon-
strated by Figure 1 C and D and confirmed by the GAM (P value
of smooth terms < 0.05). sTfR concentrations appeared to
steadily decrease as CRP increased for CRP concentrations
>5 mg/L. There appeared to be an inverted U-shaped relation
between sTfR and AGP, with the apex at an AGP concentration
of;1.5 g/L (Figure 1 D). In line with the observation that sTfR
concentration appeared to decrease in individuals with inflam-
mation, crossvalidation revealed no advantage of using more
complex GAMs and quadratic models over linear models in
terms of the RMSEs, which were 0.426, 0.427, and 0.429 for
the GAMs and quadratic and linear models, respectively, that
included APPs in continuous form as predictors. The remainder
of the analysis was therefore based on the linear models.
RMSEs for models not presented in Table 2 can be found in
Supplemental Table 1. Similarly to the SF models, the sTfR
models performed better if APPs were included in continuous
as opposed to categorical form, and performance was further
improved if morbidity covariates were added (Table 2). When
both CRP and AGP were included in the models, only CRP
remained significant. CRP was associated with a decrease in
sTfR, whereas malaria, fever, and acute diarrhea were associ-
ated with higher concentrations of sTfR (Table 2).
TABLE 2 Prediction models for log-transformed SF and sTfR in 1564 young children from Burkina Faso1
Log SF2,3 Log serum sTfR3,4
Coefficient (95% CI) P RMSE5 Coefficient (95% CI) P RMSE5
Model 1: inflammation categories 1.027 0.432
CRP .5 mg/L 0.253 (20.11, 0.625) 0.2 0.142 (20.014, 0.299) 0.07
CRP .5 mg/L and AGP .1 g/L 1.094 (0.969, 1.220) ,0.001 0.149 (0.096, 0.202) ,0.001
AGP .1 g/L 0.432 (0.305, 0.559) ,0.001 0.147 (0.094, 0.201) ,0.001
Model 2: acute-phase proteins in continuous form 0.957 0.429
CRP 0.015 (0.012, 0.018) ,0.001 20.003 (20.004, 20.002) ,0.001
AGP 0.454 (0.338, 0.571) ,0.001 —
Model 3: acute-phase proteins in continuous form and morbidity 0.927 0.410
CRP 0.014 (0.010, 0.017) ,0.001 20.004 (20.006, 20.003) ,0.001
AGP 0.348 (0.232, 0.463) ,0.001 —
Malaria 0.426 (0.310, 0.541) ,0.001 0.259 (0.209, 0.309) ,0.001
Lower respiratory tract infection 0.139 (0.008, 0.269) 0.04 —
History of fever 0.316 (0.177, 0.455) ,0.001 —
Fever — 0.072 (0.009, 0.136) 0.03
Acute diarrhea — 0.132 (0.029, 0.234) 0.01
1 AGP, a1-acid glycoprotein; CRP, C-reactive protein; RMSE, root mean square error; SF, serum ferritin; sTfR, soluble transferrin receptor.
2 Model 1: adjusted R2 = 0.159; model 2: adjusted R2 = 0.238; model 3: adjusted R2 = 0.293.
3 SF was measured in mg/L, and sTfR in mg/L.
4 Model 1: adjusted R2 = 0.023; model 2: adjusted R2 = 0.023; model 3: adjusted R2 = 0.113.
5 From 10-fold crossvalidation.
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Comparison of study-generated and meta-analysis CFs for
adjusting SF. The ratio of geometric means between the
reference and the inflammation groups did not differ from the
ones calculated in children in the meta-analysis by Thurnham
et al. (15). The ratio for the group with elevated CRP and AGP
compared with the group without inflammation generated based
on our data was different from the one calculated by Thurnham
et al. (15) for the subgroup of infants (<12 mo of age), but did
not differ for the other 2 groups (Table 3). However, if a
comparison was made only based on infants <12 mo of age in
our data as well, this difference disappeared (data not shown).
Impact of adjustment on estimated prevalence of ID.
Adjusting SF concentrations for the impact of inflammation and
infection led to a lower mean SF and a higher estimated
prevalence of ID in the sample by 12, 14, and 17 percentage
points for model 1 (linear model with inflammation categories as
predictor), model 2 (linear model with APPs as continuous
variables), and model 3 (linear model with APPs as continuous
variables and morbidity covariates), respectively (Table 4). The
impact of the adjustment of SF is also shown in Figure 2A and B.
The estimated prevalence based on adjustment with the use of
models 2 or 3 was very close to the prevalence of ID in the subset
of children without inflammation and without inflammation
and/or infection (Table 4). The estimated prevalence calculated
with the use of model 1, which corresponds to the CF approach,
was slightly lower than that based on the other 2 models.
Adjusting sTfR concentrations reduced the prevalence of ID by 7
percentage points based onmodel 1 and increased the prevalence
of ID by 3 and <1 percentage points when based on model 2 and
model 3, respectively (Table 4). As also demonstrated in Figure 2
C and D, the impact of adjustment on sTfR was therefore small.
Discussion
Our results confirm that the relations between the 2 APPs, CRP
and AGP, and biomarkers of iron status are not completely
linear. Nevertheless, linear models perform well and there was
no advantage in using the more complex quadratic model or
GAMs to predict SF and sTfR concentrations.
To adjust SF for inflammation, the use of regression models is
an alternative, and it may be preferable to the CF approach for
several reasons. First, the relation between the APPs and SF is
fairly linear for concentrations above thresholds used to indicate
inflammation, and in terms of predictive performance, there
does not appear to be any advantage of using more flexible
models. Second, we observed higher SF with increasing severity
of inflammation; as a result, models performed better if CRP
and AGP were treated as continuous rather than dichotomous
variables. Third, although the difference in RMSE between
model 2 and 3 and resulting prevalence of ID was small, the
results indicate that including morbidity leads to a more precise
TABLE 4 Estimated prevalence of ID with and without adjustment in 1564 6–23 mo old children with
moderate acute malnutrition1
n
SF, mg/L Serum sTfR, mg/L
Median (IQR) ID,2 % (n) Median (IQR) ID,2 % (n)
Without adjustment
All participants 1564 33.4 (13.5–74.0) 21.0 (329) 12.6 (9.1–17.3) 82.9 (1296)
Participants with inflammation (CRP .5 and/or AGP .1) 1070 44.4 (18.9–91.6) 14.7 (157) 13.3 (9.7–18.2) 85.7 (917)
Participants without inflammation 494 18.9 (9.5–40.4) 34.8 (172) 11.2 (8.4–15.3) 76.7 (379)
Participants without inflammation and/or illness 174 15.4 (9.3–29.2) 38.6 (66) 8.14 (8.05–8.23) 72.4 (126)
With adjustment3
Model 1: linear model with inflammation groups4 1564 19.6 (9.2–31.3) 32.9 (516) 11.4 (8.3–15.6) 75.6 (1182)
Model 2: linear model with CRP and AGP as continuous variables5 1564 17.5 (8.7–33.5) 35.4 (553) 13.1 (9.6–18.1) 86.1 (1347)
Model 3: linear models with CRP, AGP, and morbidity6 1564 16.0 (8.0–30.0) 38.3 (587) 12.4 (9.2–16.9) 83.6 (1305)
1 AGP, a1-acid glycoprotein; CRP, C-reactive protein; ID, iron deficiency; SF, serum ferritin; sTfR, soluble transferrin receptor.
2 Cutoffs used to define ID were serum ferritin ,12 mg/L and serum sTfR .8.3 mg/L.
3 Only biomarker concentrations in individuals with inflammation (CRP.5 mg/L and AGP.1 g/L) were adjusted (n = 1070), but median and
percentage ID refer to the full sample.
4 Inflammation categories included 1) no inflammation, 2) CRP.5 mg/L, 3) CRP.5 mg/L and AGP.1 g/L, and 4) AGP.1 mg/L. Model 1 is
equivalent to the correction factor approach described by Thurnham et al. (15).
5 In the sTfR model, only CRP was significant.
6 Morbidity variables included in the serum ferritin model were malaria, lower respiratory tract infection, and history of fever. Those in the
sTfR model were malaria, fever, and acute diarrhea.
TABLE 3 Comparison of study-generated and meta-analysis geometric mean ferritin ratios for
inflammation groups and group with no inflammation1
Study generated
(n = 1564)
Meta-analysis2
Infants (n = 1278) P 3 Children (n = 3695) P 3
CRP .5 mg/L vs. no inflammation 1.29 (0.89, 1.87) 1.13 (0.9, 1.41) 0.54 1.56 (1.22, 1.99) 0.36
CRP .5 mg/L and AGP .1 mg/L vs. no inflammation 2.99 (2.63, 3.39) 2.09 (1.66, 2.63) 0.006 2.55 (1.37, 4.72) 0.61
AGP .1 mg/L vs. no inflammation 1.54 (1.36, 1.75) 1.42 (1.14, 1.76) 0.52 1.53 (1.15, 2.04) 0.97
1 Values are ratios (95% CIs). AGP, a1-acid glycoprotein; CRP, C-reactive protein.
2 Geometric mean ferritin ratios for infants aged ,12 mo and children aged ,18 y from a meta-analysis carried out by Thurnham et al. (15).
3 Based on approximate t tests.
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estimate; however, including morbidity is not possible in the CF
approach. Lastly, the estimated adjusted prevalence of ID based
on linear models 2 and 3 was similar to the prevalence of ID in
the subset of children without inflammation or without inflam-
mation and infection, respectively. Overall, as expected, adjust-
ment of SF with the use of the 3 models led to an increase in
estimated prevalence of ID, which is consistent with findings of
previous studies (10, 18, 20, 22).
A disadvantage of regression analysis is that it is more
complex than the CF approach and requires available popula-
tion data. It is unclear exactly how large a sample would be
required to allow prediction models to be obtained from
regression techniques, but we estimate that for sample sizes
<50, the data would not be sufficiently informative.
Although we believe that regression analysis with the use of
both APP and morbidity data would give a more reliable
estimate of iron status and is preferable at the population level,
for example, when evaluating effectiveness of interventions, it is
not practical in a clinical setting for identification of ID in an
individual unless the regression coefficients and devices are
available to carry out the calculations. In this case, the use of a
CF would be better. Interestingly, even though morbidity
appears to play an important role, we found no differences in
CFs calculated in apparently healthy children as part of a meta-
analysis (15) compared with the ones we calculated as part of
our study. In clinical settings in which a regression approach
would be impractical and in which population data are not
available, the use of meta-analysis CFs may therefore be
appropriate to adjust SF even in children with moderate acute
malnutrition.
In the case of sTfR, the models also performed better if both
APPs and morbidity covariates were included. However, al-
though in the case of SF it makes sense to pick the best-
performing model for adjustment, this may not be the case for
sTfR. As previously mentioned, there is still some debate as to
whether sTfR should be adjusted for inflammation (10, 21–23),
and there are discrepancies in the literature regarding the
relation between sTfR and inflammation or infection. We found
a negative relation between CRP and sTfR, as others have
previously reported (6, 7). Therefore, because lower sTfR is
associated with better iron status, this would suggest better iron
status in individuals with elevated CRP. sTfR is a marker of
erythropoiesis, as well as tissue ID (5), and lower concentrations
of sTfR in children with inflammation may be a result of
suppression of erythropoiesis, which occurs possibly through the
actions of inflammatory cytokines (32). In contrast, we and
others (9, 10, 33, 34) found higher concentrations of sTfR in
individuals with malaria. It is possible that erythropoiesis is
depressed during and increases shortly after the acute malaria
infection stage. In line with this, it has been shown that although
erythropoietin is increased in malaria (35, 36), the bone marrow
response to erythropoietin may be suppressed until the parasites
have been cleared (36). We measured malaria with the use of a
rapid diagnostic test, which can stay positive for >1 mo
following treatment (37, 38), so it is not possible to know
whether a positive test reflects current or recent malaria.
However, as previously mentioned, in contrast to our results,
others have observed positive relations between inflammation
FIGURE 2 Impact of adjusting biomarker concentrations on relation
with acute-phase proteins in 1564 children aged 6–23 mo in Burkina
Faso. Impact of adjusting SF on relation with CRP (A); impact of
adjusting sTfR on relation with CRP (B); impact of adjusting SF on
relation with AGP (C); and impact of adjusting sTfR on relation with
AGP (D). Gray dots indicate unadjusted SF or sTfR concentrations and
black dots indicate values adjusted for inflammation. Adjusted SF and
sTfR concentrations were calculated with the use of regression
coefficients for CRP, AGP, and morbidity covariates from linear models
predicting log-transformed SF and sTfR concentrations. AGP, a1-acid
glycoprotein; CRP, C-reactive protein; SF, serum ferritin; sTfR, soluble
transferrin receptor.
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markers and sTfR (10–14) or shown that sTfR decreased in
malaria (8). In addition to increased erythropoiesis, higher sTfR
concentrations in children with infections may also be due to
poorer iron status. Adjusting for morbidity may therefore lead to
overadjustment. However, adjustment for CRP may be justified,
because elevated concentrations of CRP in our study were
associated with lower concentrations of sTfR, and inflammation
may therefore lead to underestimation of ID, but the impact in
our study was small. Overall, taking into consideration the
inconsistencies in the literature regarding the association between
sTfR and inflammation, the possible risk of overadjustment (if
adjusting for morbidity as well as CRP), and the fact that the
impact of adjustment was small on the whole, we believe there
is no benefit from adjusting sTfR, which is in agreement with
findings from other studies (21, 22).
We found a large difference in estimated prevalence of ID
based on sTfR and SF, even after adjustment, which is consistent
with the findings of other studies (10, 14, 22, 39, 40). Because SF
and sTfR measure different aspects of iron status, differences in
prevalence may not be surprising. However, the large difference in
prevalence may also have other causes. First, the difference may
be related to the cutoffs used. There are no internationally agreed-
upon cutoffs for sTfR (4), and the appropriateness of the 12 mg/L
cutoff for SF has also been questioned (41). However, although
both lower (41) and higher (42) cutoffs for SF in infants under
12 mo of age have been suggested, the European Society for
Paediatric Gastroenterology, Hepatology, and Nutrition commit-
tee on nutrition concluded in a position paper that the 12 mg/L
cutoff leads to over- rather than underestimation of ID (43),
which would not explain the differences we found. Second, it has
also been suggested that SF and sTfR may not be useful for
diagnosis of ID until 9 mo of age (41), but excluding children
<9 mo did not really affect prevalence of ID based on sTfR,
as well as adjusted or unadjusted SF (data not shown). Further-
more, although we adjusted SF for inflammation, we did not
account for the fact that children with inflammation and/or
infection may also be more iron deficient than children without
inflammation, and the estimated prevalence of ID after adjust-
ment may be underestimated. Lastly, SF may also be affected by
other factors, such as liver disease (44), and there may be other
unknown causes of elevated sTfR in this population, such as
thalassemia (45) and sickle cell anemia (5). A limitation of our
study is that we did not collect data on hemoglobinopathies. A
further limitation is that we were not able to compare adjustments
to a gold standard for ID, namely, bone marrow iron, and it is
therefore difficult to say which biomarker with which adjustment
for inflammation best reflects iron status in this population.
In conclusion, regression analysis is an alternative and may be
preferable to the CF approach when adjusting SF for inflamma-
tion, because it allows for accounting for severity of inflammation
and morbidity, and we recommend investigating whether this
approach would prove to be useful in other populations as well.
However, in clinical settings, in which the regression approach
would be impractical, the use of meta-analysis CFs may be
appropriate. We furthermore believe that there is no benefit from
adjusting sTfR. Moreover, considering the large difference in
estimated prevalence of ID based on SF and sTfR, more research is
needed as to which biomarker, which cutoffs for the markers, and
which adjustment can best define iron status of children from low-
income areas with high infectious disease burden.
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